Azimuth Capital Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3M | Buy |
109,277
+1,179
| +1% | +$219K | 0.75% | 38 |
|
|
2025
Q1 | $22.6M | Buy |
108,098
+339
| +0.3% | +$71K | 0.9% | 27 |
|
|
2024
Q4 | $19.1M | Buy |
107,759
+6,388
| +6% | +$1.14M | 0.74% | 40 |
|
|
2024
Q3 | $20M | Buy |
101,371
+1,309
| +1% | +$259K | 0.78% | 35 |
|
|
2024
Q2 | $17.2M | Buy |
100,062
+13,750
| +16% | +$2.36M | 0.7% | 43 |
|
|
2024
Q1 | $15.7M | Sell |
86,312
-354
| -0.4% | -$64.5K | 0.65% | 51 |
|
|
2023
Q4 | $13.4M | Sell |
86,666
-2,310
| -3% | -$358K | 0.61% | 56 |
|
|
2023
Q3 | $13.3M | Buy |
88,976
+587
| +0.7% | +$87.5K | 0.65% | 48 |
|
|
2023
Q2 | $11.9M | Sell |
88,389
-10,446
| -11% | -$1.41M | 0.57% | 58 |
|
|
2023
Q1 | $15.8M | Sell |
98,835
-2,058
| -2% | -$328K | 0.78% | 33 |
|
|
2022
Q4 | $16.3M | Sell |
100,893
-2,354
| -2% | -$380K | 0.83% | 31 |
|
|
2022
Q3 | $13.9M | Sell |
103,247
-4,474
| -4% | -$600K | 0.76% | 37 |
|
|
2022
Q2 | $16.5M | Buy |
+107,721
| New | +$16.5M | 0.83% | 27 |
|